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Background Postpartum haemorrhage (PPH) causes substantial
morbidity and mortality worldwide. A reliable prognostic tool for
PPH has potential to aid prevention efforts.
Objective Systematically to identify and appraise prognostic
modelling studies for prediction of PPH.
Search strategy MEDLINE, Embase, CINAHL and the Cochrane
Library were searched using a combination of terms and
synonyms including ‘prediction tool’, ‘risk score’ and ‘postpartum
haemorrhage’.
Selection criteria Any observational or experimental study
developing a prognostic model for women’s risk of PPH. English
language publications.
Data collection and analysis Predesigned data extraction form to
record: data source; participant criteria; outcome; candidate
predictors; actual predictors; sample size; missing data; model
development; model performance; model evaluation;
interpretation.
Main results Of 2146 citations screened, 14 studies were eligible
for inclusion. Studies addressed populations of women who
experienced placenta praevia, placenta accreta spectrum, vaginal
birth, caesarean birth (CS) and the general obstetric population.
All studies were at high risk of bias due to low sample size, no
internal validation, suboptimal or no external validation or no
reporting or handling of missing data. Five studies raised
applicability concerns. Three externally validated and three
internally validated studies show potential for robust external
validation.
Conclusion Of 14 prognostic models for PPH risk, three have
some potential for clinical use: in CS, in placenta accreta
spectrum disorders with MRI placental Evaluation and in placenta
praevia. Future research requires robust internal and external
validation of existing tools and development of a model for use in
the general obstetric population.
Keywords Postpartum haemorrhage, prediction model, prediction
tool.
Tweetable abstract Current PPH prediction tools need external
validation: one for CS, one for placenta praevia and one for
placenta accreta. Tools are needed for labouring women.
Linked article This article is commented on by S Contag, p. 54 in
this issue. To view this mini commentary visit https://doi.org/10.
1111/1471-0528.16390.
Please cite this paper as: Neary C, Naheed S, McLernon DJ, Black M. Predicting risk of postpartum haemorrhage: a systematic review. BJOG 2021;128:46–53.
Introduction
Postpartum haemorrhage (PPH) remains a leading cause of
morbidity and mortality globally, and was the second high-
est cause of direct maternal death in the UK in 2013–
2015.1
The incidence of PPH is problematic in developing
countries but is also noted to be increasing in developed
countries.2,3 Early diagnosis is essential in the management
of PPH, but diagnosis of PPH itself also presents a chal-
lenge due to the reliance upon quantification of the volume
of blood loss. For vaginal delivery, cut-offs for haemor-
rhage are typically over 500 ml of blood loss and for cae-
sarean section (CS) over 1000 ml.4,5
Prevention of PPH could be achieved through identifica-
tion of women at highest risk, allowing for measures to be
taken for active management of third stage of labour, the
presence of experienced clinicians and immediate access toSystematic review registration number: PROSPERO 95587.
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resources such as oxytocin infusion and tranexamic acid.
There are numerous studies identifying individual risk fac-
tors for PPH,6,7 but these don’t reliably identify women at
greatest risk by combining multiple risk factors. A combi-
nation of risk factors is common in practice but quantify-
ing the associated risk without the aid of a clinical
prediction model is challenging. Once a reliable and high
performing prediction model is developed, this could be
converted into a user-friendly tool such as an online risk
calculator or embedded within electronic health records.8
A review by Kleinroueler et al. (2016) found over 200
prognostic models available in obstetrics, three of which
related to PPH.9 The review found very few models in any
area of obstetrics that were being applied in routine clinical
practice and the majority of studies did not present model
formulas to allow researchers to conduct independent
external validation of the models.10
To advance efforts to identify women at risk of PPH as
early and accurately as possible, a systematic review of
existing prognostic models was considered essential. This
would enable assessment of existing models for their suit-
ability for immediate use, or identify those which perform
well internally but require external validation on an inde-
pendent cohort before consideration for clinical use. This
approach has potential to be more efficient than the addi-
tion of a new model to aid prevention of PPH.9
Since publication of the aforementioned review, several
attempts at developing prognostic models for PPH have
been published. This review aims systematically to identify
and appraise studies which develop prognostic models that
can predict the chance of PPH in pregnant women.
Methods
This review adhered to principles outlined in guidance
published by PRISMA (Preferred Reporting Items for Sys-
tematic Reviews and Meta-analysis),11 CHARMS (CHecklist
for critical Appraisal and data extraction for systematic
Reviews of prediction Modelling Studies) and PROBAST
(Prediction model risk of bias assessment tool for studies
developing, validating or updating prediction models).12
The protocol for this review has been published by PROS-
PERO and is available online.13
A literature search was conducted from 1946 to 25 May
2020 in the following databases: MEDLINE, Embase,
CINAHL and the Cochrane Library, following liaison with
a librarian. To inform the full search strategy, a limited
search of MEDLINE was first conducted followed by an
extensive search of the literature of the aforementioned
databases. Hand-searching of reference lists of included
articles was also performed. A copy of the search strategy
for MEDLINE and Embase is available in Appendix S1.
The main search terms were ‘predict$’, ‘risk score’ and
‘postpartum haemorrhage’ with the appropriate synonyms
adopted.
Inclusion criteria and exclusion criteria for this review
are outlined in Table 1. Titles and abstracts were indepen-
dently screened by two reviewers (CN and SN) and any
disagreements resolved by a third reviewer (MB).
Data extraction and risk of bias/applicability assessment
(at study level) were conducted independently in accor-
dance with the CHARMS checklist and PROBAST tools,
respectively. The risk of bias review allowed identification
of potential bias in primary studies and identified limita-
tions to applicability of the results. Items extracted from
each study included: source of data; participants; outcome
to be predicted; candidate predictors (or index tests); sam-
ple size; missing data; model development; model perfor-
mance; model evaluation; results and interpretation
(including whether authors deemed their model fit for pur-
pose or nature of further research required before using).
The PROBAST tool incorporates assessment of risk of bias
and applicability relating to the data source, the predictors
and outcome assessed, and the analysis. This includes
whether the data source has appropriately included or
excluded women to allow a correct probability to be calcu-
lated and whether the participants match the review ques-
tion. Assessment of bias in model performance due to
predictors includes the definition and measurement of pre-
dictors, e.g. bias could arise due to knowledge of the out-
come data when assessing predictors or lack of availability
of the predictors when the model is intended to be used.
PROBAST supports assessment of the outcome studied by
considering how it was determined, how objective it is,
whether it incorporates any predictor data, how consis-
tently it was determined across individuals, timing of deter-
mination, whether this was independent of knowledge of
Table 1. Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Observational studies Studies which aim only to




Studies only describing tools
for diagnosis of PPH
Pregnant women over the age of
16
Studies investigating a single
predictor test or marker
Development or validation of a
prognostic multivariable tool or
model to predict risk of PPH
Case-reports
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predictor information and whether it matches the review
question. Aspects of the analysis considered in the PRO-
BAST tool include sample size (ideally at least 20 events
per candidate predictor for model development studies),
handling of continuous and categorical predictors, handling
of missing data, method used to select predictors, how
complexities in the data were accounted for, evaluation of
model performance and accounting for model overfitting
and optimism. The findings were tabulated and a narrative
synthesis performed. The findings address the baseline
characteristics of the studies, the type of models included,
risk of bias in model performance and the applicability of
the models to clinical practice.
There was no patient involvement in development of this
review.
Results
The search strategy identified 2146 citations; following
removal of duplicates and screening, 56 full-text articles
were assessed for eligibility (PRISMA Flow Diagram, Fig-
ure 1). This review included 14 studies14–27 with a total of
14 final prediction models identified.
The populations of the included studies are shown in
Tables S1 and S2. Five studies16,18,21,22,27 included only
women with placenta praevia, four studies17,23–25 included
only vaginal deliveries, three studies14,15,20 had a population
consisting of CS (planned and unplanned), one study
defined population as consisting of women with placenta
accreta spectrum26 and one study19 had a population
encompassing the general obstetric population.
The key findings of the studies are detailed in Table S1,
including whether the study, as judged by the primary
study authors, is to be interpreted as exploratory (requiring
more research) or confirmatory (of use in clinical practice).
All candidate predictors and the predictors included in the
final published models is listed in Table S2. The setting of
the included studies were hospitals in the following coun-
tries; Italy, China, France, USA, UK, South Korea, Nether-
lands, Spain, Zimbabwe, Denmark and Egypt. The study
designs included were 11 cohort studies,14–16,18,20,22–24,26,27
of which one used whole population registry data,21 and
three case control studies,19,25 of which one was nested
within a population cohort.17 The number of participants
included in each study ranged from 110 in a prospective
cohort study to 56 967 in a retrospective cohort.14,27
Despite the attempt to predict PPH across all studies,
the chosen outcomes differed. Seven studies17–20,22,23,26
listed PPH or massive haemorrhage as an outcome, four
studies14–16,21 listed blood transfusion or massive blood
transfusion as an outcome, two studies24,25 reported post-
partum blood loss and one study27 had a combined out-
come of peripartum complications encompassing
perioperative blood transfusion or uterine artery embolisa-
tion or caesarean hysterectomy. There is also variation in
the definition and method of measurement of each out-
come, as shown in Table S1.
The risk of bias and applicability, assessed using the
PROBAST tool, is summarised in Table 2. Overall, there
was a high risk of bias across the studies. The participants
were deemed as a source of low risk of bias in ten stud-
ies,14–17,20,22-24,26,27 with three studies at high risk due to
large proportion of women excluded due to incomplete
data without exploration of how these women compared
with those included,18,19,21 and one at high risk due to ret-
rospective selection of women in a case–control study with
a control group at high risk of PPH.25 Eight studies were
at high risk of bias due to predictors being available only
after the birth (e.g. neonatal birthweight) or due to lack of
detail on how and when these were assessed.15–17,19,21,22,25,26
Three studies were at high risk of bias due to a lack of defi-
nition or method of measurement of the outcome to be
predicted.19,25,26 In relation to the analysis conducted, all
studies except one were deemed to be at high risk of bias.
Seven studies had a small sample size with a low number
of events per variable (EPV).16,18,21–24,27 Risk of bias for
missing data was uncertain for all papers because none
reported any missing data beyond those where women with
incomplete data were excluded at the outset.
From the 14 studies, 124 unique variables were selected
as candidate predictors (range 5–38 per study) and 64 vari-
ables selected as predictors (range 5–15 per study) in the
final models. The following predictors were found to be
predictive in two or more studies: (parity n = 4 studies),
low antenatal haemoglobin (n = 4), antepartum haemor-
rhage/bleed (n = 3), maternal age ≥35 years old (n = 4),
gestational age (n = 3), high neonatal weight (n = 2), mul-
tiple pregnancy (n = 3), body mass nicdex (BMI) ≥25
(n = 3), previous CS (n = 5), anterior placenta (n = 2) and
retained placenta (n = 2).
The predictive ability of the statistical models evaluated
using measures of calibration (concerned with agreement
between the predicted probabilities of the outcome and the
observed proportions of the outcome) and discrimination
(how well the model can differentiate between patients with
high and low risk)28 was evident in six14,15,17,21,24,26 and
six14–16,19,20,22 of 14 studies, respectively. Of the six studies
to report calibration, three21,24,26 used the Hosmer–Leme-
show (H–L) test with Kim et al., reporting good calibration
with a result of P = 0.44, Wu et al., reporting a result of
P = 0.165 and Rubio-Alvarez et al., failing to report a
result. However, the Hosmer–Lemeshow test is not recom-
mended for calibration assessment due to poor interpreta-
tion, as it does not provide a direction or magnitude of the
miscalibration and has limited power in small samples.11,29
Biguzzi presented a calibration plot demonstrating overall
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good performance; however, there was inadequate informa-
tion relating to curve development.17 Ahmadzia et al.
report calibration plots and association between predicted
probability of transfusion and observed incidence in deciles
of the risk score distribution. However, the authors have
not reported, at the very least, a Hosmer–Lemeshow test or
demonstrated a suitable calibration plot.14 The calibration
plots are described as curves but only display a point for
each decile with no 95% confidence intervals. Ideally, the
calibration slope should be reported along with a
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1849 records after duplicates removed
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Figure 1. PRISMA flow diagram.
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calibration curve demonstrating the non-parametric corre-
lation between observed outcome and predicted risk.30 Alb-
right et al.15 assessed calibration in this manner.
Discrimination was reported as the area under the receiver
operator curve (AUC) where 1 is perfect discrimination
and 0.5 is no better than a coin toss. The AUC ranged
from 0.70 to 0.9 across all studies, as shown in Table S1.
Eight studies attempted to address risk of overfitting or
optimism through internal validation. The approach used
varied from a random split of data (developing the model
in one split and testing it in another)14,15,18,20,24 to three-
fold cross-validation26 and bootstrapping techniques.17,21
Three studies described external validation which ranged
from temporal sampling (testing on a more recent sample
of data)21,24 to testing in a different geographical loca-
tion.26
Of 14 studies, eight presented validated models deemed
by their primary study authors as ready for use in clinical
practice.14,15,19–22,24,26 Two studies present equations: Alb-
right et al. developed one in women who underwent a CS
and Chen et al. developed one in women with placenta
accreta spectrum disorder. Ahmadzia et al. present an
online risk calculator developed in patients who underwent
CS and Dunkerton et al. present a decision tree based on
Hothorn et al.’s non-parametric recursive partitioning
algorithm, which was also developed in women who under-
went a CS. Kim et al. and Lee et al. presented a scoring
system developed in women with placenta praevia and
Rubio-Alvarez et al. present an EXCELTM risk tool devel-
oped in women vaginally delivering singletons. Wu et al.
presented a nomogram developed in women with placenta
accreta spectrum disorders. However, Ahmadzia et al.,
Dunkerton et al., Lee et al., Albright et al. and Chen et al.
did not externally validate their models––an important
requirement before use in clinical practice.31 The discrimi-
natory performance on external validation for Kim et al.,
Rubio-Alvarez et al. and Wu et al. models was good, with
AUCs of 0.88, 0.83 and 0.83, respectively.
Given that all studies were at high risk of bias due to
aspects of predictors, outcome or analysis, none was con-
sidered ready for clinical use by the review authors. Those
which performed reasonably well (AUC ≥0.7) in the devel-
opment phase and which withstood testing for overfitting
or optimism, are deemed suitable for robust external vali-
dation. These include Ahmadzia et al.,14 Albright et al.,15
Dunkerton et al.20 and Kim et al.21 (all for women under-
going CS), Biguzzi et al.17 and Rubio-Alvarez et al.24 (for
women having vaginal birth), Chen et al.18 (for women
with placenta praevia) and Wu et al.26 (for women with
placenta accreta spectrum disorders).
Table 2. PROBAST risk of bias/applicability assessment
Study Risk of bias Applicability Overall





+ + +  + + +  +
Albright et al.,
201915
+  +  + + +  +
Baba et al., 201516 + ? +  + + +  +
Biguzzi et al., 201217 +    +  +  
Chen et al., 201918  + +  + + +  +
Chi et al., 201619   ?  +  ?  
Dunkerton et al.,
201820
+ + +  + + +  +
Kim et al., 201721   +  + + +  +
Lee et al., 201822 +  +  +  +  
Prata et al., 201123 + + +  + + +  +
Rubio-Alvarez et al.,
201824
+ + +  +  +  
Tsu 199425     + + ?  ?
Wu et al., 201926 +   + + + +  +
Yoon et al., 201427 + + +  + + +  +
(+) indicate low risk of bias, (+/) indicate low/moderate risk of bias, () indicate high risk of bias and (?) indicate unclear risk of bias.
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This review is, to our knowledge, the first systematically to
identify published studies attempting to provide risk scor-
ing or prognostic models for prediction of PPH. Of 14
included, eight have been internally validated; three of
these include externally validated risk tools. All three are at
high risk of bias due to analytical issues. Both Kim et al.
(predicting blood transfusion [≥8 microl] following CS for
placenta praevia) and Rubio-Alvarez et al. (predicting
excessive postpartum blood loss in women with singleton
pregnancies who underwent vaginal delivery) demonstrated
low events per variable, utilised univariate analysis to select
predictors and did not describe handling of missing data.
Wu et al. (predicting postpartum haemorrhage in singleton
pregnancies with placenta accreta spectrum disorders deliv-
ered by CS) did not clearly define how the outcome was
measured and had a small number of events per candidate
predictor (which included 35 radiomic features selected
from a possible 1595). Only one study, Chi et al., demon-
strates a tool applicable to the general obstetric population,
but this requires robust internal  external validation
before being considered further for clinical use. The
remaining five studies identified are not deemed suitable
for use in clinical practice due to high risk of bias from the
analysis and lack of internal validation.
Strengths and limitations
A strength of this review is the prospective publication
of the protocol in PROSPERO and strict adherence to
this. The aim was to find a robust and clinically mean-
ingful formula or tool which could be of use to a clini-
cian in daily practice. Although all studies produced a
formula, scoring system or tool for predicting PPH, these
may not be appropriate as they may encourage use of a
poorly validated model. Numerous related studies32–34
have not published a useable tool or logistic regression
model with a formula for use by clinicians in clinical
practice, as they describe poor (or poorer than antici-
pated) performance of the model. This review benefits
from use of broad and general search criteria to max-
imise identification of relevant studies. Additionally, the
results yielded by the search strategy were double-
screened by two reviewers (CN and SN). The use of the
CHARMS checklist allowed for systematic data extraction
and use of PROBAST supported systematic assessment of
risk of bias and applicability.12
A limitation of this review is that it was not possible to
obtain three studies which might have been appropriate for
inclusion. One of these was part of an unpublished PhD
thesis35 and the other two were behind a paywall.36,37 In
addition, the value of findings may theoretically be limited
due to inclusion only of studies in English language; how-
ever, in reality, no (otherwise eligible) non-English studies
were identified in the search.
This review highlights shortcomings regarding the risk of
bias and reporting of the included studies.
Interpretation
This review suggests that there are no published prediction
tools for PPH ready for clinical use. Future research to
generate prognostic models for use specifically in elective
CS or in women aiming for vaginal birth would facilitate
advanced planning of personnel to optimise care provided.
The clinical usefulness of models generated by some of
the identified studies is limited by the target population.
Four studies17,23–25 focus on vaginal births, which is of lim-
ited use as vaginal delivery cannot be guaranteed in
advance. The circumstances during labour are subject to
change, with a risk of CS present until the fetal head is
delivered, thus the tool would no longer be applicable once
a decision for CS is made. Only one study19 produced a
scoring tool aimed at use in the general obstetric popula-
tion, but the study design was unclear and attempts to con-
tact the author were unsuccessful. That study included 923
women in Beijing, China, of whom almost half had a PPH,
and it did not assess predictive performance via internal or
external validation. Therefore, despite the presentation of
an equation to predict PPH with AUC of 0.86, its lack of
performance assessment means it cannot be recommended
for use in clinical practice.
Most studies were retrospective, meaning that some rele-
vant predictors may not have been measured, but the vast
majority of known risk factors for PPH can be assessed ret-
rospectively so this is not considered a major concern.38,39
Some studies’ prediction models or tools are clinically
unhelpful in regard to the final predictors included, as
some were not known at the time of birth. Both Biguzzi
et al. and Rubio-Alvarez et al. included neonatal birth-
weight as a predictor, which suggests that the intended
time for the nomogram and risk tool use is after weighing
of the baby, most likely once the highest risk of PPH has
passed. These models are therefore of limited value for
preparation of resources prior to birth. Estimated birth-
weight may be a more appropriate measure but has not
been included as a predictor in any model.
Use of intrapartum factors can aid risk assessment in a
dynamic scenario. Two studies23,24 have included these:
duration of the first and second stage of delivery and non-
use of uterotonics and cord traction. Intrapartum risk scor-
ing may be facilitated by use of electronic health records,
where the tool could be embedded within the system, but
otherwise it may present logistical difficulties if it requires
ongoing computer access as per Rubio-Alvarez et al.’s pro-
posed risk tool.
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Robust external validation was absent from all prediction
models identified, suggesting that this is poorly understood
and undervalued. Of the models externally validated21,24,26
all utilised Hosmer–Lemesow testing, which is not recom-
mended,28 and only two provided validation results. Inter-
nal validation is a reasonable alternative, as this assesses
how well the model performs in the underlying population
from which the model was developed, but only eight stud-
ies14,15,17,18,20,21,24,26 did this and only two considered the
model for prospective use in a population of placenta prae-
via or placenta accreta spectrum disorders.21,26
The prediction models identified were at high risk of
bias overall, with small sample size and suboptimal statisti-
cal analysis being common, and missing data not reported
in any study. Without missing data information, it is not
possible to assess fully the related risk of bias.39
The need for adequately powered studies is clear. Half
the included studies showed a low EPV (<20) with only
one24 conducting any shrinkage methods to overcome
problems arising from overfitting of the model (and risk of
optimistic predictions) when there is a low number of
events. Despite this, several authors recommended use of
affected models without external validation.14,15,18,20 As a
result of heterogeneity and low EPV, it was not possible to
conduct a meta-analysis of the results. There is potential
for individual participant data meta-analysis of findings for
predicting PPH in a population of women with placenta
praevia.
Conclusion
Three PPH risk prediction tools reviewed have potential
for clinical use pending robust external validation: one in
cases of CS (Leicester PPH predict score),20 one for the
prediction of massive transfusion in CS with known pla-
centa praevia21 and one for prediction of PPH in women
with placenta accreta spectrum disorders undergoing MRI
placental evaluation ahead of CS.26 Development and
robust validation of PPH prediction tools applicable to the
general obstetric population is needed.
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